Appalachian Mind Health Initiative
AMHI
Remote Cognitive Behavior Therapy for Major Depression (RTD) in Primary Care
1 other identifier
interventional
1,280
1 country
7
Brief Summary
We propose to carry out a treatment experiment in which we evaluate the extent to which randomizing primary care clinicians have access to remote internet-based Cognitive Behavior Therapy (eCBT) in rural West Virginia (WV) and Kentucky (KY) will help improve treatment of patients with Major Depressive Disorder (MDD). WV and KY are two of the most rural states in America and mental health treatment resources are low; especially in rural parts of the state.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Jan 2021
Longer than P75 for not_applicable major-depressive-disorder
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2019
CompletedFirst Posted
Study publicly available on registry
October 9, 2019
CompletedStudy Start
First participant enrolled
January 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedMarch 27, 2026
March 1, 2026
5 years
May 31, 2019
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
RDQ-7
Investigators will assess all study patients remission from depression with the Remission from Depression Questionnaire (RDQ-7) via self-report assessments at 16 week follow-up. Investigators will monitor patients at 26, 39, and 52 weeks to evaluate the long-term maintenance of remission (or recurrence). The RDQ-7 is a measure with 41 items. Items are reported on a 3-point rating scale (0=not at all or rarely true; 1 = sometimes; 2 = often or almost always true). The total scale score ranges from 0-82. Participants with a total score below or equal to 27 are considered in remission. Higher total scores reflect greater pathology.
16-Week Follow-up
Secondary Outcomes (3)
PROMIS Short Form v1.0 - Severity of Substance Use (past 30 days)
16 week Follow-up
Compliance with Antidepressant Medication Treatment
16 week Follow-up
SDM-Q-9
52 week Follow-up
Study Arms (3)
Primary Care Treatment
NO INTERVENTIONThe participant will receive treatment as usual as prescribed by the primary care physician for MDD.
Primary care treatment with eCBT
ACTIVE COMPARATORThe participant will receive treatment as usual as prescribed by the primary care physician with the addition of eCBT for MDD.
Primary care treatment with guided eCBT
ACTIVE COMPARATORThe participant will receive treatment as usual as prescribed by the primary care physician with the addition of guided eCBT for MDD.
Interventions
Provide access to online psychotherapy program to participants in rural WV areas at no expense to them.
Eligibility Criteria
You may qualify if:
- seeking MDD treatment for the first time in the past 6 months (i.e., the beginning of a first or new course of treatment),
- appropriate for outpatient treatment,
- literate in English,
- has access to a smart phone, home computer or willing to travel to access a computer
- without hearing or vision or cognitive impairment that would interfere with research data collection
- without history of either bipolar disorder or non-affective psychosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
University of Lousiville Health
Louisville, Kentucky, 40202, United States
Upper Kanawha Clinic
Cedar Grove, West Virginia, 25039, United States
Minnie Hamilton Health Systems
Glenville, West Virginia, 26351, United States
Minnie Hamilton Health Systems
Grantsville, West Virginia, 26147, United States
Harpers Ferry Family Medicine
Harpers Ferry, West Virginia, 25425, United States
WVU Medicine
Morgantown, West Virginia, 26505, United States
Wayne Medical Clinic
Wayne, West Virginia, 25570, United States
Related Publications (1)
Bossarte RM, Kessler RC, Nierenberg AA, Chattopadhyay A, Cuijpers P, Enrique A, Foxworth PM, Gildea SM, Belnap BH, Haut MW, Law KB, Lewis WD, Liu H, Luedtke AR, Pigeon WR, Rhodes LA, Richards D, Rollman BL, Sampson NA, Stokes CM, Torous J, Webb TD, Zubizarreta JR. The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients. Trials. 2022 Jun 20;23(1):520. doi: 10.1186/s13063-022-06438-y.
PMID: 35725644DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Bossarte, PhD
University of South Florida
- PRINCIPAL INVESTIGATOR
Ronald Kessler, PhD
Harvard Medical School (HMS and HSDM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participant recruiters will be blinded to the participant's intended treatment arm. Survey data collectors will be blinded to each participant's treatment arm.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Psychiatry and Behavioral Neuroscience
Study Record Dates
First Submitted
May 31, 2019
First Posted
October 9, 2019
Study Start
January 9, 2021
Primary Completion
December 31, 2025
Study Completion
January 30, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share